Augmenting epithelial barrier function

Journal of Epithelial Biology and Pharmacology

Volumn 5, Issue SPEC. ISSUE, 2012, Pages 10-12

  Mullin, James M ^a  

^a LANKENAU HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; HYPOXIA INDUCIBLE FACTOR; ZINC;

BLASTOCYTE; CELL COMMUNICATION; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELLULAR DISTRIBUTION; EDITORIAL; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; INTESTINE EPITHELIUM; INTRACELLULAR SIGNALING; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; THERMODYNAMICS; TIGHT JUNCTION; TISSUE CHARACTERIZATION; TISSUE DISTRIBUTION; TISSUE STRUCTURE;

EID: 84856592136     PISSN: None     EISSN: 18750443     Source Type: Journal    
DOI: 10.2174/1875044301205010010     Document Type: Editorial

References (16)

1. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286: C1213-28.
2. Guttman JA, Finlay BB. Tight junctions as targets of infectious agents. Biochim Biophys Acta 2009; 4: 832-41.
3. Gonzalez-Mariscal L, Garay E, Lechuga S. Virus interaction with the apical junctional complex. Front Biosci 2009; 14: 731-68.
4. Mullin JM, Agostino N, Rendon-Huerta E, Thornton JJ. Keynote review: epithelial and endothelial barriers in human disease. Drug Discov Today 2005; 10: 395-408.
5. Sawada N, Murata M, Kikuchi K, et al. Tight junctions and human diseases. Med Electron Microsc 2003; 36: 147-56.
6. Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104: 123-33.
7. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Annu Rev Pathol 2010; 5: 119-44.
8. Edelblum KL, Turner JR. The tight junction in inflammatory disease: communication breakdown. Curr Opin Pharmacol 2009; 9: 715-20.
9. Samarin S, Nusrat A. Regulation of epithelial apical junctional complex by Rho family GTPases. Front Biosci 2009; 14: 1129-42.
10. Steed E, Balda MS, Matter K. Dynamics and functions of tight junctions. Trends Cell Biol 2010; 20: 142-9.
11. Hering NA, Schulzke JD. Therapeutic options to modulate barrier defects in inflammatory bowel disease. Dig Dis 2009; 27: 450-4.
12. Felinski EA, Cox AE, Phillips BE, Antonetti DA. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res 2008; 86: 867-78.
13. Sheth P, Seth A, Thangavel M, Basuroy S, Rao RK. Epidermal growth factor prevents acetaldehyde-induced paracellular permeability in Caco-2 cell monolayer. Alcohol Clin Exp Res 2004; 28: 797-804.
14. Singer KL, Stevenson BR, Woo PL, Firestone GL. Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in nontransformed mammary epithelial cells. J Biol Chem 1994; 269: 16108-15.
15. Soler AP, Laughlin KV, Mullin JM. Effects of epidermal growth factor versus phorbol ester on kidney epithelial (LLC-PK1) tight junction permeability and cell division. Exp Cell Res 1993; 207: 398-406.
16. Singh AB, Harris RC. Epidermal growth factor receptor activation differentially regulates claudinexpression and enhances transepithelial resistance in Madin-Darby canine kidneycells. J Biol Chem 2004; 279: 3543-52.